{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:32:34Z","timestamp":1791660754089,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-026-01189-0","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:03:10Z","timestamp":1781600590000},"page":"1436-1453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4305-4223","authenticated-orcid":false,"given":"Yuxiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3636-5845","authenticated-orcid":false,"given":"Mingshun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0359-076X","authenticated-orcid":false,"given":"Longlong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1405-8793","authenticated-orcid":false,"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-6383","authenticated-orcid":false,"given":"Dan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5074-0109","authenticated-orcid":false,"given":"Zhihuan","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5491-8995","authenticated-orcid":false,"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1359-2518","authenticated-orcid":false,"given":"Jinyong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhen","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-342X","authenticated-orcid":false,"given":"Lingming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6213-6187","authenticated-orcid":false,"given":"Lijian","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7139-2756","authenticated-orcid":false,"given":"Huiru","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2731-489X","authenticated-orcid":false,"given":"Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-3745","authenticated-orcid":false,"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"1189_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"1189_CR2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887\u2013904 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1189_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49\u201361 (2014).","journal-title":"Immunity"},{"key":"1189_CR4","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","volume":"29","author":"P Goossens","year":"2019","unstructured":"Goossens, P. et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab. 29, 1376\u20131389 (2019).","journal-title":"Cell Metab."},{"key":"1189_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon, S. & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593\u2013604 (2010).","journal-title":"Immunity"},{"key":"1189_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00938","volume":"11","author":"TM Grzywa","year":"2020","unstructured":"Grzywa, T. M. et al. Myeloid cell-derived arginase in cancer immune response. Front. Immunol. 11, 938 (2020).","journal-title":"Front. Immunol."},{"key":"1189_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547\u2013562 (2018).","journal-title":"Cancer Cell"},{"key":"1189_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41, 421\u2013433 (2023).","journal-title":"Cancer Cell"},{"key":"1189_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.726261","volume":"9","author":"MF Renne","year":"2021","unstructured":"Renne, M. F. & Hariri, H. Lipid droplet\u2013organelle contact sites as hubs for fatty acid metabolism, trafficking, and metabolic channeling. Front. Cell Dev. Biol. 9, 726261 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1189_CR10","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","volume":"33","author":"Y Song","year":"2021","unstructured":"Song, Y., Liu, J., Zhao, K., Gao, L. & Zhao, J. Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases. Cell Metab. 33, 1911\u20131925 (2021).","journal-title":"Cell Metab."},{"key":"1189_CR11","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41590-021-01047-4","volume":"22","author":"G Di Conza","year":"2021","unstructured":"Di Conza, G. et al. Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity. Nat. Immunol. 22, 1403\u20131415 (2021).","journal-title":"Nat. Immunol."},{"key":"1189_CR12","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/s42255-021-00440-5","volume":"3","author":"G Bidault","year":"2021","unstructured":"Bidault, G. et al. SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation. Nat. Metab. 3, 1150\u20131162 (2021).","journal-title":"Nat. Metab."},{"key":"1189_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103578","volume":"72","author":"J Hoppstadter","year":"2021","unstructured":"Hoppstadter, J. et al. Dysregulation of cholesterol homeostasis in human lung cancer tissue and tumour-associated macrophages. EBioMedicine 72, 103578 (2021).","journal-title":"EBioMedicine"},{"key":"1189_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7354","volume":"6","author":"D Sag","year":"2015","unstructured":"Sag, D., Cekic, C., Wu, R., Linden, J. & Hedrick, C. C. The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity. Nat. Commun. 6, 6354 (2015).","journal-title":"Nat. Commun."},{"key":"1189_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.immuni.2024.03.021","volume":"57","author":"J Xiao","year":"2024","unstructured":"Xiao, J. et al. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages. Immunity 57, 1087\u20131104 (2024).","journal-title":"Immunity"},{"key":"1189_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00947-6","volume":"7","author":"J Xu","year":"2017","unstructured":"Xu, J. et al. PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NF\u03baB. Sci. Rep. 7, 835 (2017).","journal-title":"Sci. Rep."},{"key":"1189_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/1078-0432.CCR-13-2053","volume":"20","author":"A Erdreich-Epstein","year":"2014","unstructured":"Erdreich-Epstein, A. et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clin. Cancer Res. 20, 827\u2013836 (2014).","journal-title":"Clin. Cancer Res."},{"key":"1189_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01405-1","volume":"9","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT\/Raf-1-dependent pathway in hepatocellular carcinoma. Cell Death Discov. 9, 139 (2023).","journal-title":"Cell Death Discov."},{"key":"1189_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molmet.2018.07.010","volume":"16","author":"AW Fischer","year":"2018","unstructured":"Fischer, A. W. et al. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins. Mol. Metab. 16, 88\u201399 (2018).","journal-title":"Mol. Metab."},{"key":"1189_CR20","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.cell.2024.02.024","volume":"187","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. A gut-derived hormone regulates cholesterol metabolism. Cell 187, 1685\u20131700 (2024).","journal-title":"Cell"},{"key":"1189_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459 (2020).","journal-title":"Cell"},{"key":"1189_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845 (2019).","journal-title":"Cell"},{"key":"1189_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing, X. et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol. Cancer 18, 157 (2019).","journal-title":"Mol. Cancer"},{"key":"1189_CR24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41568-018-0048-x","volume":"18","author":"BT Finicle","year":"2018","unstructured":"Finicle, B. T., Jayashankar, V. & Edinger, A. L. Nutrient scavenging in cancer. Nat. Rev. Cancer 18, 619\u2013633 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"1189_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux, K. & Delgoffe, G. M. Metabolic barriers to cancer immunotherapy. Nat. Rev. Immunol. 21, 785\u2013797 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1189_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/01.sla.0000118751.95179.c6","volume":"239","author":"MM Abdel-Latif","year":"2004","unstructured":"Abdel-Latif, M. M. et al. NF-\u03baB activation in esophageal adenocarcinoma: relationship to Barrett\u2019s metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann. Surg. 239, 491\u2013500 (2004).","journal-title":"Ann. Surg."},{"key":"1189_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1189_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202306158","volume":"35","author":"J Liang","year":"2023","unstructured":"Liang, J. et al. Outer membrane vesicle-based nanohybrids target tumor-associated macrophages to enhance trained immunity-related vaccine-generated antitumor activity. Adv. Mater. 35, e2306158 (2023).","journal-title":"Adv. Mater."},{"key":"1189_CR29","doi-asserted-by":"crossref","unstructured":"Thaker, A. I., Shaker, A., Rao, M. S. & Ciorba, M. A. Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS). J. Vis. Exp. (67), e4100 (2012).","DOI":"10.3791\/4100-v"},{"key":"1189_CR30","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16159","volume":"11","author":"D Dzhalilova","year":"2023","unstructured":"Dzhalilova, D., Zolotova, N., Fokichev, N. & Makarova, O. Murine models of colorectal cancer: the azoxymethane (AOM)\/dextran sulfate sodium (DSS) model of colitis-associated cancer. PeerJ 11, e16159 (2023).","journal-title":"PeerJ"},{"key":"1189_CR31","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.24736","volume":"55","author":"C Ho","year":"2012","unstructured":"Ho, C. et al. AKT (v-Akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma Ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)\/SKP2, and c-Myc pathways. Hepatology 55, 833\u2013845 (2012).","journal-title":"Hepatology"},{"key":"1189_CR32","doi-asserted-by":"crossref","unstructured":"Klinke, D. J. II, Gould, A., Pirkey, A., Razazan, A. & Deng, W. A functional comparison of two transplantable syngeneic mouse models of melanoma: B16F0 and YUMM1.7. Biol. Open 14, bio062175 (2025).","DOI":"10.1242\/bio.062175"},{"key":"1189_CR33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A., Allavena, P., Marchesi, F. & Garlanda, C. Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799\u2013820 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1189_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1668","volume":"5","author":"V Bronte","year":"2005","unstructured":"Bronte, V. & Zanovello, P. Regulation of immune responses by l-arginine metabolism. Nat. Rev. Immunol. 5, 641\u2013654 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"1189_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0308-4","volume":"5","author":"SM Steggerda","year":"2017","unstructured":"Steggerda, S. M. et al. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. J. Immunother. Cancer 5, 101 (2017).","journal-title":"J. Immunother. Cancer"},{"key":"1189_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.2956","volume":"15","author":"SC Huang","year":"2014","unstructured":"Huang, S. C. et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 15, 846\u2013855 (2014).","journal-title":"Nat. Immunol."},{"key":"1189_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2020.08.040","volume":"183","author":"A Sharma","year":"2020","unstructured":"Sharma, A. et al. Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma. Cell 183, 377\u2013394 (2020).","journal-title":"Cell"},{"key":"1189_CR38","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809 (2021).","journal-title":"Cell"},{"key":"1189_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11010-010-0398-5","volume":"340","author":"Y Zhao","year":"2010","unstructured":"Zhao, Y. et al. Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytes. Mol. Cell. Biochem. 340, 41\u201348 (2010).","journal-title":"Mol. Cell. Biochem."},{"key":"1189_CR40","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/iub.2135","volume":"71","author":"Q Mu","year":"2019","unstructured":"Mu, Q. et al. Overexpression of PID1 reduces high density lipoprotein level and functionality in swine. IUBMB Life 71, 1946\u20131951 (2019).","journal-title":"IUBMB Life"},{"key":"1189_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo, J., Yang, H. & Song, B. L. Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 21, 225\u2013245 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1189_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann, J. A. & Carvalho, P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol. 20, 137\u2013155 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1189_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo, A., Cantley, L. C. & Pandolfi, P. P. Cancer metabolism: fatty acid oxidation in the limelight. Nat. Rev. Cancer 13, 227\u2013232 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"1189_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.100670","volume":"49","author":"J Kopecka","year":"2020","unstructured":"Kopecka, J. et al. Phospholipids and cholesterol: inducers of cancer multidrug resistance and therapeutic targets. Drug Resist. Updat. 49, 100670 (2020).","journal-title":"Drug Resist. Updat."},{"key":"1189_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun, Y. A. & Obeid, L. M. Sphingolipids and their metabolism in physiology and disease. Nat. Rev. Mol. Cell Biol. 19, 175\u2013191 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1189_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay4361","volume":"6","author":"GS Hussey","year":"2020","unstructured":"Hussey, G. S. et al. Lipidomics and RNA sequencing reveal a novel subpopulation of nanovesicle within extracellular matrix biomaterials. Sci. Adv. 6, eaay4361 (2020).","journal-title":"Sci. Adv."},{"key":"1189_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13238-012-2025-6","volume":"3","author":"Y Yuan","year":"2012","unstructured":"Yuan, Y., Li, P. & Ye, J. Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis. Protein Cell 3, 173\u2013181 (2012).","journal-title":"Protein Cell"},{"key":"1189_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall, A. R. & Yvan-Charvet, L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15, 104\u2013116 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1189_CR49","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang, W. et al. Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism. Nature 531, 651\u2013655 (2016).","journal-title":"Nature"},{"key":"1189_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","volume":"4","author":"JYL Chiang","year":"2020","unstructured":"Chiang, J. Y. L. & Ferrell, J. M. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Res. 4, 47\u201363 (2020).","journal-title":"Liver Res."},{"key":"1189_CR51","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1172\/JCI0216388","volume":"110","author":"I Bjorkhem","year":"2002","unstructured":"Bjorkhem, I. Do oxysterols control cholesterol homeostasis? J. Clin. Invest. 110, 725\u2013730 (2002).","journal-title":"J. Clin. Invest."},{"key":"1189_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 21, 363\u2013383 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1189_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard, K. & Krause, K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245\u2013313 (2007).","journal-title":"Physiol. Rev."},{"key":"1189_CR54","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","volume":"30","author":"IS Harris","year":"2020","unstructured":"Harris, I. S. & DeNicola, G. M. The complex interplay between antioxidants and ROS in cancer. Trends Cell Biol. 30, 440\u2013451 (2020).","journal-title":"Trends Cell Biol."},{"key":"1189_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bcp.2013.02.031","volume":"86","author":"G Segala","year":"2013","unstructured":"Segala, G. et al. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells. Biochem. Pharmacol. 86, 175\u2013189 (2013).","journal-title":"Biochem. Pharmacol."},{"key":"1189_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101324","volume":"68","author":"T Nury","year":"2021","unstructured":"Nury, T. et al. Attenuation of 7-ketocholesterol- and 7\u03b2-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: potential for the prevention of age-related diseases. Ageing Res. Rev. 68, 101324 (2021).","journal-title":"Ageing Res. Rev."},{"key":"1189_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-pathol-011110-130138","volume":"6","author":"JI Odegaard","year":"2011","unstructured":"Odegaard, J. I. & Chawla, A. Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6, 275\u2013297 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"1189_CR58","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106065","volume":"40","author":"J Tian","year":"2021","unstructured":"Tian, J. et al. 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING. EMBO J. 40, e106065 (2021).","journal-title":"EMBO J."},{"key":"1189_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17029-3","volume":"11","author":"T Wei","year":"2020","unstructured":"Wei, T., Cheng, Q., Min, Y. L., Olson, E. N. & Siegwart, D. J. Systemic nanoparticle delivery of CRISPR\u2013Cas9 ribonucleoproteins for effective tissue specific genome editing. Nat. Commun. 11, 3232 (2020).","journal-title":"Nat. Commun."},{"key":"1189_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.65","volume":"2","author":"RL Rungta","year":"2013","unstructured":"Rungta, R. L. et al. Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain. Mol. Ther. Nucleic Acids 2, e136 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1189_CR61","doi-asserted-by":"publisher","first-page":"e145296","DOI":"10.1172\/JCI145296","volume":"131","author":"X Su","year":"2021","unstructured":"Su, X. et al. Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. J. Clin. Invest. 131, e145296 (2021).","journal-title":"J. Clin. Invest."},{"key":"1189_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn8608","volume":"386","author":"A Kuratani","year":"2024","unstructured":"Kuratani, A. et al. Platelet factor 4-induced TH1\u2013Treg polarization suppresses antitumor immunity. Science 386, eadn8608 (2024).","journal-title":"Science"},{"key":"1189_CR63","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1002\/anie.202013228","volume":"60","author":"G Yang","year":"2021","unstructured":"Yang, G. et al. Acceptor engineering for optimized ROS generation facilitates reprogramming macrophages to M1 phenotype in photodynamic immunotherapy. Angew. Chem. Int. Ed. Engl. 60, 5386\u20135393 (2021).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1189_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221\u2013225 (2011).","journal-title":"Nature"},{"key":"1189_CR65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/cr.2015.63","volume":"25","author":"W Liu","year":"2015","unstructured":"Liu, W. et al. Park7 interacts with p47phox to direct NADPH oxidase-dependent ROS production and protect against sepsis. Cell Res. 25, 691\u2013706 (2015).","journal-title":"Cell Res."},{"key":"1189_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.immuni.2017.06.016","volume":"47","author":"F Di Cara","year":"2017","unstructured":"Di Cara, F., Sheshachalam, A., Braverman, N. E., Rachubinski, R. A. & Simmonds, A. J. Peroxisome-mediated metabolism is required for immune response to microbial infection. Immunity 47, 93\u2013106 (2017).","journal-title":"Immunity"},{"key":"1189_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2022.339979","volume":"1215","author":"W Lv","year":"2022","unstructured":"Lv, W. et al. Comprehensive metabolite quantitative assay based on alternate metabolomics and lipidomics analyses. Anal. Chim. Acta 1215, 339979 (2022).","journal-title":"Anal. Chim. Acta"},{"key":"1189_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26222-x","volume":"12","author":"M Niu","year":"2021","unstructured":"Niu, M. et al. FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth. Nat. Commun. 12, 5919 (2021).","journal-title":"Nat. Commun."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01189-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01189-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01189-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:02:11Z","timestamp":1790172131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01189-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1038\/s43018-026-01189-0","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}